DOse volume effects and Fibrosis in the corpora cavernosa After Radiotherapy for prostate cancer A pilot study

DOse volume effects and Fibrosis in the corpora cavernosa After Radiotherapy for prostate cancer A pilot study - DOFAR

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30681

Enrollment

Registered

2007-05-02

Start date

2007-12-06

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carcinoma of the prostate prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Histologically proven prostate cancer Online setup corrections with gold markers International Index of Erectile Function erectile function domain score of at least 13

Exclusion criteria

Exclusion criteria: Erectile dysfunction before treatment Adjuvant hormonal therapy

Design outcomes

Primary

Measure	Time frame
The primary endpoint of this study is to analyze the correlation between the radiation dose in the IPAs and ED after EBRT, based on IIEF scores.	—

Secondary

Measure	Time frame
The secondary endpoints are to test the hypothesis that RIF in the IPAs and corpora cavernosa causes ED after EBRT.	—

Countries

Netherlands

Outcome results